Under construction – not a live service
Sign in
Taking people in EgyptNo phase

Heat-Based Ablation Treatment for Lung Tumors in Lung Cancer Patients

Tests heat-based needle treatment to destroy lung cancer tumors in patients who cannot have surgery.

Plain-language title generated from the registry record
Registry title: Percutaneous Thermal Ablation in Lung Tumors

Key facts

Where
Asyut, EgyptSee the site

Where in Egypt

  • Faculty of medicineAsyut, EgyptTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Assiut University
Trial code
NCT06891183
Record updated
24 March 2025
Original description
Lung cancer has a high incidence globally, with Egypt having it as the third most common and most lethal cancer, affecting 16.9% of males and 3.8% of females. While surgery is the preferred treatment for stage 1 non-small cell lung cancer due to positive outcomes, it carries significant risks due to patient comorbidities. Non-invasive treatments like radio frequency ablation (RFA) and microwave ablation (MWA) are alternatives for those unable to undergo surgery. These techniques use energy to destroy tumor tissue with minimal invasiveness and can be guided by computed tomography to ensure accurate ablation.Read full original descriptionShow less

Percutaneous Thermal Ablation in Treatment of Lung Cancer

Lung cancer has a high incidence globally, with Egypt having it as the third most common and most lethal cancer, affecting 16.9% of males and 3.8% of females. While surgery is the preferred treatment for stage 1 non-small cell lung cancer due to positive outcomes, it carries significant risks due to patient comorbidities. Non-invasive treatments like radio frequency ablation (RFA) and microwave ablation (MWA) are alternatives for those unable to undergo surgery. These techniques use energy to destroy tumor tissue with minimal invasiveness and can be guided by computed tomography to ensure accurate ablation.

Inclusion: lung cancer smaller than 5 cm; metastasis to the lung; patients with lung cancer and multiple comorbidities who are unfit for surgery.

Exclusion: lung cancer larger than 5 cm; lung cancer stage II or more; patients who cannot tolerate CT guided needle placement for thermal ablation of lung tumors.

ClinicalTrials.gov NCT06891183